Defensin vs Tachyplesin — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Defensins are a superfamily of small, cysteine-rich cationic antimicrobial peptides that form a critical component of innate immunity across virtually all multicellular organisms. In humans, alpha-defensins (HNP-1 to -4 in neutrophils; HD-5, HD-6 in intestinal Paneth cells) and b...
Calculate Defensin dose →Tachyplesin I is an 18-residue disulfide-bridged beta-hairpin AMP from the hemocytes of the Japanese horseshoe crab (Tachypleus tridentatus). It exhibits potent antimicrobial, antiviral, and antitumor activity....
Calculate Tachyplesin dose →| Parameter | Defensin | Tachyplesin |
|---|---|---|
| Category | Antimicrobial Peptide | Antimicrobial Peptide |
| Research | Research/Therapeutic Development | Preclinical |
| Half-Life | Minutes-hours (tissue dependent) | Hours (disulfide stabilized) |
| Typical Dose | Research only | N/A |
| Frequency | N/A | N/A |
| Route | Endogenous; topical/intranasal (research) | Research only |
| FDA Status | No approval (research stage) | Not approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.